Webdisclosure.com

Search

SANOFI-AVENTIS (EPA:SAN) Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis

Directive transparence : information réglementée

20/09/2019 12:48